Jefferies Assumes Zai Lab (ZLAB) at Buy; 'Huge Biotech Tailwinds in China'
Tweet Send to a Friend
Jefferies analyst Michael Yee assumes coverage on Zai Lab (NASDAQ: ZLAB) with a Buy rating and a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
